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Background: mHealth is a promising means of supporting
adherence to treatment. The Start TB patients on ART and Retain
on Treatment (START) study included real-time adherence support
using short-text messaging service (SMS) text messaging and trained
village health workers (VHWs). We describe the use and accept-
ability of mHealth by patients with HIV/tuberculosis and health
care providers.
Methods: Patients and treatment supporters received automated,
coded medication and appointment reminders at their preferred time
and frequency, using their own phones, and $3.70 in monthly
airtime. Facility-based VHWs were trained to log patient information
and text message preferences into a mobile application and were
given a password-protected mobile phone and airtime to communi-
cate with community-based VHWs. The use of mHealth tools was
analyzed from process data over the study course. Acceptability was
evaluated during monthly follow-up interviews with all participants
and during qualitative interviews with a subset of 30 patients and 30
health care providers at intervention sites. Use and acceptability were
contextualized by monthly adherence data.
Findings: From April 2013 to August 2015, the automated SMS
system successfully delivered 39,528 messages to 835 individuals,
including 633 patients and 202 treatment supporters. Uptake of the
SMS intervention was high, with 92.1% of 713 eligible patients
choosing to receive SMS messages. Patient and provider interviews
yielded insight into barriers and facilitators to mHealth utilization.
The intervention improved the quality of health communication
between patients, treatment supporters, and providers. HIV-related
stigma and technical challenges were identified as potential barriers.
Conclusions: The mHealth intervention for HIV/tuberculosis
treatment support in Lesotho was found to be a low-tech, user-
friendly intervention, which was acceptable to patients and health
care providers.
Key Words: mobile health, mHealth, SMS, tuberculosis, HIV/
AIDS, adherence
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BACKGROUND
Mobile health (mHealth) is a promising means of
improving adherence to medication and clinic appointments
thereby potentially improving clinical outcomes.1 Mobile
technology allows health care providers to communicate
remotely with patients and more easily reach rural populations
with poor or challenging transportation infrastructure.2 The
number of mobile phone subscriptions in sub-Saharan Africa
has been rising more rapidly than anywhere else in the world,3–5
allowing for innovative use of inexpensive mHealth technolo-
gies such as short-text messaging service (SMS). However, the
results of recent studies using SMS reminders for antiretroviral
therapy (ART) adherence from resource-limited settings have
been mixed, with some studies showing an improvement6–9 and
others showing no benefit.10,11 Recent meta-analyses using
evidence from randomized controlled trials have demonstrated
that weekly SMS is efficacious at improving self-reported ART
adherence.12–14
The Start TB patients on ART and Retain on Treatment
(START) study is an innovative mixed methods cluster-
randomized trial that evaluated the effectiveness, cost-
effectiveness, and acceptability of a combination intervention
package (CIP) versus standard of care (SOC) to improve early
ART initiation and retention during tuberculosis (TB) treat-
ment, as well as TB treatment success, among patients with
HIV/TB in Lesotho. Study methods have been described
elsewhere,15 but in brief, 12 health facilities in the Berea
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district were randomized to receive CIP vs. SOC from April
2013 to August 2015. The CIP included a range of pro-
grammatic, structural, and psychosocial components, including
real-time patient adherence support using mHealth technology
and trained village health workers (VHWs). VHWs are
community-based lay health workers who, subsequent to being
trained under the Ministry of Health, provide essential health
services at the community and household level, including
health education, social welfare, and preventive health care
services and the timely referral of individuals who are in need
of facility-based medical care.
The aim of this article is to describe the use and
acceptability of the mHealth component of the START study




The mHealth intervention comprised the design and
delivery of a standardized, automated SMS system to provide
real-time adherence support to patients on HIV and TB
treatment. The study team developed a simple SMS reminder
application using CommCare, an open source mobile plat-
form developed by Dimagi (http://www.dimagi.com/),
a Boston-based health informatics service provider that has
supported many public health projects in developing coun-
tries. Tools available online were used to build an application
to send appointment and medication SMS reminders to
mobile phones based on a predefined algorithm. SMS
messages were sent “one-way,” which meant that recipients
could not respond.
In Lesotho, patients with HIV and TB routinely identify
a treatment supporter, usually a family member, to assist with
day-to-day treatment support. For this study, patients and
treatment supporters were given a choice to have the SMS
reminders sent to either one of them, or simultaneously to
both. Two types of SMS reminders were sent at the
recipients’ preferred time of day: appointment reminders
were sent 2 days and 1 day before patients’ scheduled
monthly clinic appointments and medication reminders were
sent daily for the first 6 weeks of ART, and daily or weekly
thereafter according to individual preferences. Patients and
treatment supporters selected the time of day they wanted to
receive appointment and medication reminders. Medication
reminders used code words (“Did you eat your meal today?”)
to protect patients’ confidentiality. Patients were not issued
study phones because mobile phone usage at study initiation
was found to be relatively high (.85%); additionally, it was
assumed that there was mobile phone reception throughout
the study district. Patients with access to a working phone
were provided with approximately $3.70 in monthly airtime
to facilitate communication with their VHW or nurse in case
of difficulties; incoming SMS messages did not incur
a charge.
At each START CIP facility, 1–2 VHWs were selected
to be facility-based VHWs and to coordinate the activities of
VHWs providing community-based patient support. Facility-
based VHWs were provided with password-protected mobile
phones with the customized CommCare application and SMS
text message capability, as well as monthly airtime to facilitate
patient follow-up and support and to contact community-based
VHWs. Nurses were also given monthly airtime to refer
potential participants to research staff. Facility-based VHWs
were trained to log patients’ information and preferred message
time and frequency in the mobile phone application. Data were
transmitted to a secure cloud server in South Africa that
received the parameters entered by the VHWs and sent
outgoing messages in bulk to patients and treatment supporters
(Fig. 1). CommCare provided access to patient data as well as
data on outgoing messages on a secure Web site, which helped
the study team troubleshoot emergent problems, such as
network and registration issues. The study team used the
CommCare reports module to monitor outgoing messages and
to evaluate the implementation process. Facility-based VHWs
provided detailed SMS instructions to patients and treatment
supporters, including practice exercises, to ensure their comfort
and familiarity with mobile technology.
Data Collection and Analysis
mHealth use and acceptability were assessed using
mixed methods. mHealth use was quantitatively analyzed from
study process data, drawn from a monthly Program Character-
istics Survey to track CIP implementation, and an intervention
receipt log for SMS messages and mobile airtime to document
the “dosage”16 of mHealth that was received by study patients
and treatment supporters at the CIP sites. mHealth acceptability
was assessed using questions about intervention acceptability
that were integrated into monthly follow-up interviews and
qualitatively evaluated via in-depth interviews with a purposive,
heterogeneous subset of patients and health care providers,
6–12 months post study initiation, at the CIP sites. The use and
acceptability of mHealth tools were contextualized by adher-
ence data, drawn from monthly follow-up interviews with
371 patients (measurement cohort) at CIP and SOC sites during
the course of TB treatment (6–9 months).15
FIGURE 1. Architecture of the SMS system.
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All monthly follow-up interviews were based on
standardized questionnaires and administered face-to-face
by trained research assistants. All qualitative interviews were
based on a semi-structured guide, conducted face-to-face by
separate trained staff not directly involved in patient care, and
thematically analyzed using a grounded theory approach.17
Ethics and Consent Process
The study was reviewed and approved by the
Columbia University Medical Center Institutional Review
Board and the Lesotho National Health Research and
Ethics Committee. Written informed consent was obtained
from all participants completing study questionnaires and
interviews. The study was registered at ClinicalTrials.
gov (NCT01872390).
FINDINGS
Evaluation of mHealth Use
Over the study course of 29 months, the automated
SMS system successfully delivered 39,528 messages to
835 individuals who consented to receive study SMS
messages. Of 713 patients who were eligible for SMS
reminders at CIP sites, 657 (92.1%) consented to receive
the mHealth intervention, with no difference by gender.
Most patients received SMS messages on their own (n =
455); 24 treatment supporters received SMS messages on
behalf of their patients; and in 178 cases, patients and their
treatment supporters received the same SMS message
(Fig. 2). Ninety-six patients (15.2%) switched from daily
to weekly medication reminders and did so on average
45.4 6 39.1 days after enrollment; a small number of
patients [n = 15 (15.6%)] subsequently switched back to
daily medication reminders.
Evaluation of Intervention Acceptability
During monthly follow-up interviews, 171 measure-
ment cohort participants in CIP sites were asked what had
made it easier or helped them take their TB medications or
ART; 41.9% stated the SMS messages were a facilitator to
adherence in at least 1 monthly follow-up interview. No
measurement cohort participant reported that the SMS
messages posed a challenge to adherence in follow-
up interviews.
Between February 2014 and January 2015, in-depth
qualitative interviews were completed with 30 health care
providers and 30 patients, approximately equally distributed
across the CIP sites. Health care provider participants
included 10 nurses and 20 VHWs with median 12 and 18
years of experience, respectively, providing services for
patients and communities affected by HIV and/or TB.
VHW participants included 7 facility-based VHWs and 13
community-based VHWs. Patient participants were on aver-
age 38.16 9.7 years old, 43.3% were women, and 73.3% had
a primary education or no formal education; these socio-
demographic characteristics are representative of the popula-
tions served by participating health facilities (Table 1).
Literacy, defined by the ability to read a full sentence, was
found in 83.3% of patient participants. Most patient partic-
ipants (83.3%) reported owning a mobile phone; 30.0%
reported electricity in the house.
Patient Acceptability
Patient participants were appreciative of the mHealth
intervention. They perceived the appointment and medication
reminders were complementary cues to adherence, alongside
visits from VHWs, and appreciated being able to self-select
the time and frequency of messages. Most patient participants
FIGURE 2. Patients (PT) and treatment supporters (TS) who
received SMS messages.






Mean age, yrs (SD) 37.6 (10.4) 38.1 (9.7)
Female gender, n (%) 79 (41.4) 13 (43.3)
Education, n (%)
Did not attend school 12 (6.3) 2 (6.7)
Primary 123 (64.4) 20 (66.7)




21 (11.0) 3 (10.0)
Marital status, n (%)
Married/living
together
103 (53.9) 17 (56.7)
Divorced/separated/
widowed
50 (26.2) 9 (30.0)
Never married 38 (19.9) 4 (13.3)
Literacy, n (%)
Able to read whole
sentence
143 (74.9) 25 (83.3)
Own mobile phone,
n (%)
171 (89.5) 25 (83.3)
Have electricity in the
house, n (%)
69 (36.1) 9 (30.0)
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also understood the coded text messages were a form of
private health communication.
“It [ie, SMS] helps me a lot because you may find
that it is time when I get back home from work.
and by then I am tired, and I will just hear ringing
phone, then when I take the phone to read I find
out that it is the message that reminds me.” (male
participant, age 35 years)
“I think the one that remind me to take my
medication being the first class [ie, excellent], I
don’t make any mistake with the medication I
fear and I can’t miss them at all.” (male
participant age 29 years)
“They don’t cause any problems because each
and every one has his [own] phone and is
private.” (female participant, age 26 years)
Patient participants were very appreciative of the
airtime provided by the study. Phone calls, above and beyond
SMS messages, empowered them to communicate with their
health care providers and treatment supporters in a timely
manner, without incurring a personal cost. Patients said they
more frequently called their provider to report a side effect,
seek advice, or inform their clinic about potential delays to
a clinic appointment. They also felt more inclined to call and
request assistance from their treatment supporters.
“We are given airtime that we use it to commu-
nicate with our supporters if we have a problem.”
(female participant, age 31 years)
However, several participants reported routinely tak-
ing medications on their own with the aid of a phone alarm
or were sufficiently reminded by their relatives, treatment
supporter, or VHW. Although they appreciated receiving
reminders for times when they were preoccupied or
fatigued, they perceived the SMS service to be less
necessary.
“My remembrance is that because I have
a paper which I constantly mark in the morning
and evening. It is the one which gives me
understanding that in the morning when I have
taken some, I mark. there was no way I would
say I have forgotten to take them. I have
a programme of how to go accordingly.” (male
participant, age 28 years)
“You know these ones of TB I am still reminded
by this person who is close to me, who is my
wife, the one who comes and wakes me and also
do things to help me. These ones of the afternoon
which are the ARVs I am still able to, even
[despite] the SMS enters to remind me.” (male
participant, age 38 years)
A few patient participants did not use or own a phone.
They had registered their treatment supporter to receive SMS
reminders, who in turn, reminded them to take medications.
As a result, they did not fully understand or appreciate the
utility of the SMS service.
“This little lady [ie, my daughter] is the one who
supports me. She is the one who would be telling me
that, “Hey, it’s time”. She has a phone. I don’t
have a phone myself. I have not received them [ie,
SMS] personally.” (female participant, age 56 years)
Patients who were generally less familiar with mobile
phones were at times confused by the coded messages.
Nonetheless, they managed to link the SMS messages to
medication intake.
“It [ie, SMS] says “have you eaten supper” it
reminds me that I have to eat before I take
medication.” (male participant, age 35 years)
Unstable access to electricity and temporary technical
difficulties appeared to bar a few patient participants from
receiving regular SMS reminders.
“This phone has issue because at home we don’t
have electricity it keeps giving us trouble as to
where we charge and what to do like that.”
(female participant, age 52 years)
“There was a time when they [ie, SMS] were not
coming through, but when I arrived here, I came to
report it here and they said, there was a bit of
a challenge but it is all well.” (male participant, age
53 years)
Health Care Provider Acceptability
Health care provider participants reported receiving
sufficient training and technical support to partake in phone-
related study activities. They expressed support for the mHealth
component of the intervention as it facilitated communication
between patients, treatment supporters, and the various cadres
of providers engaged in the CIP.
Facility-based VHWs appreciated the flexibility of being
able to use study-issued phones for text messages as well as
phone calls. Nurses and facility-based VHWs reported patients
expressed feeling more cared for when they were followed up
more frequently. Often, patients preferred to talk by phone
rather than type a text message. Text messages and airtime were
thereby understood to strengthen the patient–provider bond.
“Actually, the importance and goodness of airtime
is communication, because, at times I left the patient
not feeling well, so maybe when I’m at home I will
call to ask how she is feeling and she answers. That
is the goodness of airtime. Even when it comes to
the patients, I find it very good because it
encourages them, showing them that they are cared
for, they are assisted with health. Even if they have
nothing, they should have airtime.” (VHW)
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Community-based VHWs appreciated being able to
monitor patients over phone, as they faced substantial geo-
graphic barriers and unpredictable weather when following
patients living in disparate, remote rural areas. Some VHWs
would call patients nearly every day to remind them to take
daily doses and to ensure that they made it to their next clinic
visit with the appropriate tools in hand such as sputum
samples. This helped to avoid delays at the facility, capture
and resolve potential reasons for missing a visit, and prevent
nonadherence. Routine communication helped them triage
patients for emerging medical complications or adverse drug
effects more efficiently and support patients through difficult
periods in their treatment in a more meaningful way. VHWs
were also more easily able to track and follow-up with
patients at risk for nonadherence or treatment interruption.
“The use of SMS is very important. suppose it
rains heavily and I am unable to attend him, I text
him and say, ‘It is your time now. Have you
remembered your food?’ He already knows. I will
have taught him that when I say that, I mean it’s
time to take his pills. So it is very helpful this
SMS thing, it helps us meet our patients.” (VHW)
VHWs were sensitive to patients’ experiences with
HIV-related stigma and supported the use of simple, coded
text messages that protected patients’ privacy and confiden-
tiality. However, they worried that study calls could disrupt
dynamics within households where patients had not disclosed
their HIV status. In consultation with such patients, VHWs
developed innovative, patient-acceptable strategies to protect
against inadvertent breaches in confidentiality.
“It is very important, . the way it [ie, SMS] is
written. If it says, have you taken medication.
[if] you find that somone’s phone is in the wrong
hands, then they get to know the patient’s issues
too soon.” (VHW)
“The case of Mrs. [name], when she was with the
in-laws, her case was her secret. I would call,
make her a callback. She was familiar with my
number and if she did not respond to it I would
know that the clouds have covered [ie, there are
people around]. But if I make her a callback and
she does the same, I knew that it’s clear and so we
can talk.” (VHW)
Akin to reports from patient participants, health care
providers also experienced technical challenges with the SMS
service; most were quickly resolved after discussions with
study staff or affected patients.
“When I was initially taught it was a bit of
a struggle to understand as quick. But I ultimately
got it even though a phone at times can give you
problems here and there, and you find that here it
gives a delivery report and at the head office
where it is supposed to be sent to they say it does
not arrive but when we fix that problem again you
find that it goes through smoothly. For others you
find that the patient has given you a certain
number, in a blink of an eye he has changed it
without telling you that he doesn’t use that
number anymore.” (VHW)
Evaluation of Adherence
Data from monthly adherence assessment interviews
among measurement cohort participants found that self-
reported 30-day adherence to 100% of ART were 86.3% in
the CIP versus 80.7% in SOC, and to TB medications was
89.1% in CIP versus 79.5% in SOC (Table 2); adherence did
not vary by gender. Among patient participants in the
qualitative evaluation (N = 30), the proportion reporting
100% adherence to ART and TB medications was higher, at
90.0% and 93.3%, respectively.
DISCUSSION
In this mixed-methods implementation science study
evaluating the use and acceptability of a CIP to improve early
ART initiation and retention, and TB treatment success among
HIV/TB patients in Lesotho, the mHealth component of the
intervention package was considered beneficial by both patients
and health care providers. Intervention delivery process data
highlighted very high uptake of the SMS intervention among
both male and female patients. The perceived importance of SMS
messages in supporting adherence also arose during patients’
monthly follow-up interviews and in-depth qualitative interviews.
Qualitative interviews revealed many overlaps between
the viewpoints of patient and health care provider participants.
Drivers of mHealth use included: cues to adherence, for
medication intake and clinic appointments; access to airtime,
via the issuance of vouchers; ability to place outgoing calls as
well as to send SMS messages; personal choice in selecting the
time and frequency of incoming SMS messages; and the use of
private SMS messages (Fig. 3). These factors were perceived
to enhance the quality and frequency of communication
TABLE 2. Self-Reported Adherence
CIP (n = 183),
N (%)
SOC (n = 166),
N (%)
Measurement cohort
Average monthly adherence to
ART—100%
158 (86.3) 134 (80.7)
Average monthly adherence to TB
medications—100%
163 (89.1) 132 (79.5)
Patient participants in the qualitative
evaluation*
Average monthly adherence to
ART—100%
27 (90.0) UK
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between patients and providers and between VHWs and
nurses, with positive impacts on patient–provider inter-
actions, provider workload, and quality of care. The interviews
also allowed us to identify 2 groups of patients among whom
the mHealth component of the CIP was of less perceived value
or less appreciated. This included patients with existing
adherence supports who may have had less need for additional
cues and patients who had not disclosed their HIV status to
household members and were thus less comfortable reading
text messages at home or in public places. Technical challenges
and confusion related to general phone use may have also
impeded optimal utilization of the SMS service.
The optimal frequency of providing SMS messages to
patients has not been clear. In early 2012 when this study was
designed, the only 2 SMS trials published were from Lester
et al (2010),6 who tested a weekly SMS message and found it
effective, and Pop-Eleches et al (2011),8 who compared
weekly and daily SMS messages and found that weekly
messages had a positive effect on adherence, whereas daily
messages did not have an effect on adherence. In the START
study, we chose to provide daily messages for the first 6
weeks of HIV/TB cotreatment and then to allow patients
choose whether to continue daily messages or switch to
weekly messages. It is interesting to note that only 15.2% of
patients elected to switch from daily to weekly medication
reminders and a percentage of those (15.6%) subsequently
switched back to daily reminders.
Overall, delivery of the mHealth intervention was found
to be inexpensive, as one server can provide SMS messages to
thousands of patients in a large geographic area with very few
human resources needed beyond the initial setup. The applica-
tion was developed using an open source mobile platform.
During 29 months of study implementation, the costs for
troubleshooting the application before intervention launch and
providing SMS services to 835 individuals totaled $3124; study-
issued airtime vouchers totaled $22–33 per patient or treatment
supporter, depending on the length of cotreatment. During
dissemination of study results, the Lesotho Ministry of Health
(MOH) indicated an interest in rolling out implementation of the
SMS intervention in a programmatic setting; however, they did
not commit to the provision of airtime.
A 2011 systematic review of ART adherence in 20
countries found the average rate of reporting $90% ART
adherence is 62%.18 This level of adherence in HIV mono-
infected individuals is significantly lower than what was seen
in our study, where 86.3% and 89.1% of HIV/TB co-infected
patients in the CIP arm reported adherence levels of 100% to
HIV and TB medications, respectively; a trend of higher
adherence was noted in the CIP arm versus the SOC arm. The
study design precludes evaluation of the effectiveness of
individual components of the CIP; however, process data and
qualitative analyses have highlighted patient and health care
provider perspectives on the utility and acceptability of the
mHealth intervention.
There are several implications to be drawn from our
findings. First, mHealth interventions are more likely to be
successful if they allow for flexibility in SMS/call capability,
frequency, and timing and are accompanied with training and
technical support, routine patient instruction (eg, on phone
use and coded messages), and consideration of regional
infrastructure (eg, network, electricity). Although airtime
provision may increase intervention uptake and is likely to
enhance acceptability, it is more costly and its adoption would
depend on local feasibility and resources. Second, the
potential challenge of HIV stigma should be recognized and
addressed in context-specific ways as HIV nondisclosure, an
established proxy for stigma,19 may interfere with mHealth
uptake. Third, although SMS technology is relatively inex-
pensive, in highly resource-constrained settings, it may be
reserved for those patients who lack other sources of social
and adherence support.
The study has several limitations. Unlike other studies
that either provided a mobile phone8,20 or required access to
one,6,9,21 phone ownership was not an inclusion criterion for
the CIP. Patients without mobile phones may be different
from those who have access to phones, thus limiting
generalizability of our findings. However, given our imple-
mentation science framework and focus on sustainability, we
did not find it feasible to issue study phones in this resource-
limited setting. Another limitation is in the lack of precision
in measuring dosage of the mHealth intervention. Similar to
other mHealth studies,8 participants in the CIP were not asked
to respond to SMS messages. One-way messages precluded
us from being certain that messages were received and read
by the individual patient. Adherence may have been over-
reported in monthly follow-up interviews due to social
desirability bias. To protect patient confidentiality, we did
not link patients’ phone numbers and study IDs, and thus we
could not compare adherence levels of patients who received
daily versus weekly adherence reminders. We were also
unable to interview treatment supporters and learn from their
unique experiences as recipients of the SMS intervention.
FIGURE 3. Determinants of mHealth acceptability and uptake
among patient participants. HH, household.
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The study has several strengths. First, this is a mixed-
methods implementation science trial. As such, we carefully
measured intervention implementation processes as well as
dosage of the intervention received. Additionally, we inte-
grated mixed methods,22,23 which allowed us to assess
barriers and facilitators for medication adherence and to
evaluate the acceptability and utilization of the SMS inter-
vention. Second, the participating health facilities have
adequate heterogeneity, covering both urban and rural loca-
tions, which strengthens the external validity of findings.
Third, more than half of the study sample were men, a group
that is often hard to reach and support, and thus our findings
can inform adherence and retention strategies targeting this
priority population to achieve epidemic control. Finally,
having the support and engagement of the MOH in the design
and implementation phases of this study has fostered MOH
ownership at the national and district levels and will help to
ensure sustainability of the mHealth intervention.
CONCLUSION
The mHealth intervention for HIV/TB treatment sup-
port in Lesotho was found to be a low-technology, user-
friendly intervention, which was acceptable to patients and
health care providers.
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